Aceclidine

Aceclidine
Clinical data
Other namesLNZ101
AHFS/Drugs.comVizz
License data
Routes of
administration		Topical (ophthalmic solution)
ATC code
Legal status
Legal status
Identifiers
IUPAC name
  • 1-Azabicyclo[2.2.2]oct-3-yl acetate; 3-Quinuclidinyl Acetate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.011.431
Chemical and physical data
FormulaC9H15NO2
Molar mass169.224 g·mol−1
3D model (JSmol)
SMILES
  • O=C(OC2C1CCN(CC1)C2)C
InChI
  • InChI=1S/C9H15NO2/c1-7(11)12-9-6-10-4-2-8(9)3-5-10/h8-9H,2-6H2,1H3
  • Key:WRJPSSPFHGNBMG-UHFFFAOYSA-N

Aceclidine (Glaucostat, Glaunorm, Glaudin) is a parasympathomimetic miotic agent used in the treatment of narrow angle glaucoma.

Aceclidine was approved for medical use in the United States in July 2025.[2]

  1. ^ https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218585s000lbl.pdf
  2. ^ "Novel Drug Approvals for 2025". U.S. Food and Drug Administration (FDA). 4 August 2025. Retrieved 5 August 2025.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.